Managed Care

 

Select SSRIs increase level of HMO drug formulary access despite generic incursion

MANAGED CARE March 2003. © MediMedia USA
The Formulary Files

Select SSRIs increase level of HMO drug formulary access despite generic incursion

MANAGED CARE March 2003. ©MediMedia USA











Generic versions of Prozac (fluoxetine) have been available to patients for approximately 18 months, and a court decision is expected this month on whether generic Paxil (paroxetine hydrochloride) may be marketed. Yet in the face of this, several SSRI brands have increased HMO drug formulary access.

We analyzed 2001 and 2003 data from MediMedia's Formulary Compass database for the HMO market. GlaxoSmithKline's Paxil's "approved" status (approved, tier 1, tier 2, tier 3) increased from 91 percent to 98 percent of patients since generic versions of Prozac became available. At the same time, the requirement for prior authorization of Paxil fell from 6 percent of patients to 1.5 percent of patients in 2003. A similar situation can be found with Pfizer's Zoloft. Zoloft increased its approved status from 87 percent to 90 percent of patients. Celexa now has approved status for 78 percent of patients, with the newest entrant into this market, Lexapro, at 57 percent.

MediMedia's Formulary Compass is a constantly updated compilation of formulary information containing product position for over 3,000 separate drug benefit designs for HMOs, PPOs, PBMs, POS plans, Medicaid, employer groups, and private insurers.

SOURCE: MEDIMEDIA INFORMATION TECHNOLOGIES

Meetings

2014 Annual HEDIS® and Star Ratings Symposium Nashville, TN November 3–4, 2014
PCMH & Shared Savings ACO Leadership Summit Nashville, TN November 3–4, 2014
Medicare Risk Adjustment, Revenue Management, & Star Ratings Fort Lauderdale, FL November 12–14, 2014
World Orphan Drug Congress Europe 2014 Brussels, Belgium November 12–14, 2014
Healthcare Chief Medical Officer Forum Alexandria, VA November 13–14, 2014
Home Care Leadership Summit Atlanta, GA November 17–18, 2014
6th Semi-Annual Diagnostic Coverage and Reimbursement Conference Boston December 4–5, 2014
Customer Analytics & Engagement in Health Insurance Chicago December 4–5, 2014
Pharmaceutical and Biotech Clinical Quality Assurance Conference Alexandria, VA December 4–5, 2014
9th Semi-Annual Medical Device Coverage and Reimbursement Conference San Diego December 5, 2014
8th Annual Medical Device Clinical Trials Conference Chicago December 8–9, 2014
HealthIMPACT Southeast Tampa, FL January 23, 2015